News
No 3D for children under age six
Friday, November 21 2014 | 00 h 00 min | Vision Science
A French agency recommends zero exposure to 3D movies and video games for children under six years of age, and limiting usage of these devices for kids under 13.
Read MoreVisionix and the Axis Medical Group enter into exclusive distribution agreement for Canada
Thursday, November 20 2014 | 00 h 00 min | News
Visionix and the Axis Medical Group have announced the signing of an exclusive distribution agreement for Canada, effective January 1, 2015.
Read MoreValeant acquires Nicox’s US subsidiary
Wednesday, November 19 2014 | 00 h 00 min | News
Valeant acquires Nicox Inc., Nicox's US subsidiary specialized in diagnostic tests.
Read MoreVision-Ease Lens names John Weber as CEO
Tuesday, November 18 2014 | 00 h 00 min | News
Vision-Ease Lens has named John Weber as its new chief executive officer.
Read MoreActavis to acquire Allergan
Monday, November 17 2014 | 00 h 00 min | News
Actavis and Allergan announced that they have entered into a definitive agreement under which Actavis will acquire Allergan.
Read MoreUniversity of Waterloo develops new treatment for dry eyes
Friday, November 14 2014 | 00 h 00 min | Vision Science
Scientists from the University of Waterloo have developed a nanoparticle-based topical solution to combat dry eyes with a single weekly application.
Read MoreAppointments at OSI
Friday, November 14 2014 | 00 h 00 min | News
Optometric Services Inc. (OSI) has announced the appointment of Karina Dandavino as the director of marketing.
Read MoreSales growth at Sàfilo
Thursday, November 13 2014 | 00 h 00 min | News
The North American market is the driving force behind Safilo’s third quarter growth.
Read MoreNovartis and Alcon deliver solid results
Wednesday, November 12 2014 | 00 h 00 min | News
Novartis and its Alcon division delivered a good performance in the third quarter of 2014.
Read MoreRecord quarter for Allergan
Wednesday, November 12 2014 | 00 h 00 min | News
In the third quarter of 2014, Allergan posted its strongest sales increase in the company’s history Allergan’s sales were CA$2 billion in the...
Read More

